Company profile: Burl Concepts
1.1 - Company Overview
Company description
- Provider of a portable, battery-powered ultrasound device for non-invasive, transcranial brain perfusion assessment and stroke diagnosis. The SONAS system uses microbubble contrast agents to detect cerebral blood perfusion differences.
Products and services
- SONAS®: A battery-powered, transcranial ultrasound device that non-invasively assesses brain perfusion using microbubble contrast agents to detect cerebral blood perfusion differences for stroke diagnosis.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Burl Concepts
Premier Biotech
HQ: United States
Website
- Description: Provider of drug testing diagnostic devices and laboratory services, including drugs of abuse testing delivering accurate results in under 10 minutes with observed collection to prevent adulteration. Offers the OT-Scan app for capturing and reporting drug screen results with automated test interpretation, secure data transmission, and in-app confirmation testing ordering.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Premier Biotech company profile →
Inbrain Neuroelectronics
HQ: Spain
Website
- Description: Provider of graphene-based brain-computer interface therapeutics and precision neurology solutions that combine high-resolution, skin-like BCI decoding with micrometric modulation in a closed loop to deliver adaptive, personalized treatments for Parkinson’s disease, epilepsy, and stroke. Offerings include implantable neural processors, an AI-powered therapy platform, and Innervia systems for vagus nerve modulation.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Inbrain Neuroelectronics company profile →
Silo Pharma
HQ: United States
Website
- Description: Provider of developmental-stage biopharmaceutical research merging traditional therapeutics with psychedelic research, developing: SPC-15, an intranasal 5-HT(4) receptor agonist for PTSD and stress-induced anxiety; SP-26, a ketamine-based injectable dissolvable implant for chronic pain and fibromyalgia; SPC-14, an intranasal compound for Alzheimer’s targeting NDMARS and 5HT4Rs to treat cognitive and neuropsychiatric symptoms; and SPU-16, a CNS homing peptide for MS and other neuroinflammatory pathologies, improving delivery and reducing toxicity of therapeutics.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Silo Pharma company profile →
Edge Therapeutics
HQ: United States
Website
- Description: Provider of biotechnology-driven therapies created by transforming FDA-approved drugs to address unmet acute neurological conditions.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Edge Therapeutics company profile →
Entheon Biomedical
HQ: Canada
Website
- Description: Provider of biotechnology research and development focused on developing and commercializing safe and effective DMT-based psychedelic therapeutic products to treat addiction and substance use disorders, subject to regulatory approvals; an addiction recovery solution harnessing and optimizing the therapeutic potential of the DMT molecule.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Entheon Biomedical company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Burl Concepts
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Burl Concepts
2.2 - Growth funds investing in similar companies to Burl Concepts
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Burl Concepts
4.2 - Public trading comparable groups for Burl Concepts
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →